Find and Pitch Jounalists, Get Your Story Covered

Tags: Tesla electric vehicles sales IBM qubit

	Profile	Recent Articles on Subject
1	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? - 8 days ago Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study - about 1 year ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 10 days ago FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 24 days ago To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach - 8 months ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - 17 days ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 3 months ago Teva Launches Generic Formulation of Liraglutide in US - 5 months ago Counsel Patients on Nutrition and Following a Balanced Diet Complementary to GLP-1s - 6 months ago Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients - 7 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 9 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 11 months ago
4	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Ars Live: What else can GLP-1 drugs do? Join us Tuesday for a discussion. - 19 days ago
5	Rachael Robertson MedPage Today Investigations & enterprise writer. Covers ob/gyn. @medpagetoday. NYC via PGH Investigative writinghealthcare	GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids - 20 days ago
6	Kristen Monaco MedPage Today	Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening - 2 months ago Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - 3 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 4 months ago Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers - 4 months ago No Link Between GLP-1 Drugs and Suicide, Says European Regulator - 7 months ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - 8 months ago One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? - 8 months ago FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now - 10 months ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - 10 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 12 months ago Tirzepatide Wins FDA Approval for Weight Loss - about 1 year ago FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes - about 1 year ago Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. - about 1 year ago
7	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Can GLP-1 drugs help with type 1 diabetes? - 2 months ago STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 2 months ago Can you get satiety with GLP-1s without the nausea? - 4 months ago STAT+: Pfizer says it will advance once-daily GLP-1 pill after all - 4 months ago Parkinson’s disease may be helped by GLP-1 drug, new study finds - 7 months ago GLP-1 drugs not linked to suicidal thoughts in FDA’s early review - 10 months ago STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds - 11 months ago
8	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 2 months ago
9	Alex Carchidi Motley Fool Writer, consultant, entrepreneur. Motley Fool. Boston, Massachusetts writingconsultingentrepreneurshipfinance	This GLP-1 Biotech Stock Could Give Novo Nordisk a Run for Its Money - 3 months ago
10	MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Which GLP-1 Drug Was Tied to a Signal of Suicidal Thoughts? - 3 months ago

Journalists covering glucagon like peptide 1